他汀类药物在脑卒中治疗中的地位

被引:10
作者
章顺轶
袁莹
机构
[1] 复旦大学附属华山医院静安分院老年病科
关键词
缺血性脑卒中; 他汀类; 药物; 相关性; 治疗;
D O I
暂无
中图分类号
R743.3 [急性脑血管疾病(中风)];
学科分类号
摘要
脑卒中与他汀类药物的关系已经在近几年的流行病学研究中被确认,并逐渐引起临床医生的重视。有研究发现在脑卒中治疗中,早期或大剂量使用他汀类药物能显著获益,这除了他汀类药物有效的降脂效果外,其多效性效应起到了重要作用,对认清脑卒中和他汀类药物之间关系非常必要。尽管有报道称他汀类药物有可能会增加颅内出血风险,又或者存在肌病及转氨酶升高等不良反应,但他汀类药物还是安全的,且对于缺血性脑卒中患者而言,服用他汀类药物带来的获益更明显。现就近年有关脑卒中与他汀类药物之间的相关性研究进展做一综述。
引用
收藏
页码:680 / 685
页数:6
相关论文
共 24 条
  • [2] Venous Thrombosis Associated with HMG-CoA Reductase Inhibitors[J] . Giuseppe Lippi,Emmanuel Favaloro,Fabian Sanchis-Gomar.Semin Thromb Hemost . 2013
  • [3] Continued statin therapy could improve the outcome after spontaneous intracerebral hemorrhage
    Tapia-Perez, J. H.
    Rupa, R.
    Zilke, R.
    Gehring, S.
    Voellger, B.
    Schneider, T.
    [J]. NEUROSURGICAL REVIEW, 2013, 36 (02) : 279 - 287
  • [4] Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association[J] . Karen L. Furie,Scott E. Kasner,Robert J. Adams,Gregory W. Albers,Ruth L. Bush,Susan C. Fagan,Jonathan L. Halperin,S. Claiborne Johnston,Irene Katzan,Walter N. Kernan,Pamela H. Mitchell,Bruce Ovbiagele,Yuko Y. Palesch,Ralph L. Sacco,Lee H. Schwamm,Sylvia Wassertheil-Smoller,Tanya N. Turan,Deidre
  • [5] Recent Nationwide Trends in Discharge Statin Treatment of Hospitalized Patients With Stroke
    Ovbiagele, Bruce
    Schwamm, Lee H.
    Smith, Eric E.
    Hernandez, Adrian F.
    Olson, DaiWai M.
    Pan, Wenqin
    Fonarow, Gregg C.
    Saver, Jeffrey L.
    [J]. STROKE, 2010, 41 (07) : 1508 - 1513
  • [6] Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis[J] . Vasilios G Athyros,Konstantinos Tziomalos,Thomas D Gossios,Theodora Griva,Panagiotis Anagnostis,Konstantinos Kargiotis,Efstathios D Pagourelias,Eleni Theocharidou,Asterios Karagiannis,Dimitri P Mikhailidis.The Lancet . 2010 (9756)
  • [7] Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis[J] . Min Jun,Celine Foote,Jicheng Lv,Bruce Neal,Anushka Patel,Stephen J Nicholls,Diederick E Grobbee,Alan Cass,John Chalmers,Vlado Perkovic.The Lancet . 2010 (9729)
  • [8] Effect of In-Hospital Initiation of Lipid-Lowering Therapy on Six-Month Outcomes in Patients With Acute Ischemic Stroke or Transient Ischemic Attack
    Yeh, Poh-Shiow
    Lin, Huey-Juan
    Bai, Chyi-Huey
    Hsieh, Fang-I
    Ke, Der-Shin
    Li, Yi-Heng
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (10) : 1490 - 1494
  • [9] Rosuvastatin in the Prevention of Stroke Among Men and Women With Elevated Levels of C-Reactive Protein: Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)[J] . Brendan M. Everett,Robert J. Glynn,Jean G. MacFadyen,Paul M Ridker.Circulation . 2010 (1)
  • [10] Prior use of statins and outcome in patients with intracerebral haemorrhage[J] . R.Eichel,S. T.Khoury,T.Ben‐Hur,M.Keidar,R.Paniri,R. R.Leker.European Journal of Neurology . 2009 (1)